COVID-19 vaccine: China’s public good versus ‘America First’
A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing, capital of China, March 16, 2020. (Xinhua/Zhang Yuwei) With more than 20 million confirmed cases worldwide, people are waiting anxiously for news of a...